Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Inflammation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Inflammasomes < Inflammation < Infliximab  Facettes :

List of bibliographic references indexed by Inflammation

Number of relevant bibliographic references: 93.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000318 (2020) Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne]Interleukin-6: A Masterplayer in the Cytokine Network.
000766 (2019) Narjes Babchia [France] ; Solange Landreville [Canada] ; Bruno Clément [France] ; Cédric Coulouarn [France] ; Frédéric Mouriaux [France]The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment.
000850 (2019) Thor Ueland [Norvège] ; Ola Kleveland [Norvège] ; Annika E. Michelsen [Norvège] ; Rune Wiseth [Norvège] ; Jan Kristian Dam S [Norvège] ; Kirsten B. Holven [Norvège] ; P L Aukrust [Norvège] ; Lars Gullestad [Norvège] ; Arne Yndestad [Norvège] ; Bente Halvorsen [Norvège]Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.
000970 (2019) Yanli Zhao [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Huiyun Wang [République populaire de Chine] ; Pengfei Chen [République populaire de Chine] ; Chen He [République populaire de Chine] ; Zhiming Cai [République populaire de Chine] ; Lisha Mou [République populaire de Chine] ; Shaodong Luan [République populaire de Chine] ; Hanchao Gao [République populaire de Chine]Potential pathological role of pro-inflammatory cytokines (IL-6, TNF-α, and IL-17) in xenotransplantation.
000A81 (2019) Bhagirathbhai R. Dholaria [États-Unis] ; Christina A. Bachmeier [États-Unis] ; Frederick Locke [États-Unis]Mechanisms and Management of Chimeric Antigen Receptor T-Cell Therapy-Related Toxicities.
000B89 (2019) Juan Shan [République populaire de Chine] ; Jiabi Zhang [République populaire de Chine]Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
000C66 (2019) Rosalie M. Sterner [États-Unis] ; Reona Sakemura ; Michelle J. Cox ; Nan Yang ; Roman H. Khadka ; Cynthia L. Forsman ; Michael J. Hansen ; Fang Jin ; Katayoun Ayasoufi ; Mehrdad Hefazi ; Kendall J. Schick ; Denise K. Walters ; Omar Ahmed [États-Unis] ; Dale Chappell [États-Unis] ; Tarek Sahmoud [États-Unis] ; Cameron Durrant [États-Unis] ; Wendy K. Nevala ; Mrinal M. Patnaik ; Larry R. Pease ; Karen E. Hedin ; Neil E. Kay ; Aaron J. Johnson ; Saad S. KenderianGM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
001100 (2018) Wen-Chan Chiu [Taïwan] ; Han-Ming Lai [Taïwan] ; Chi-Hua Ko [Taïwan] ; Jia-Feng Chen [Taïwan] ; Chung-Yuan Hsu [Taïwan] ; Ying-Chou Chen [Taïwan]Ultrasound is more reliable than inflammatory parameters to evaluate disease activity in patients with RA receiving tocilizumab therapy.
001151 (2018) J. Ruiz-Medrano [Espagne] ; D. Díaz-Valle [Espagne] ; R. Cui A [Espagne] ; J A Gegúndez [Espagne] ; J. Chhablani [Inde] ; P D Majumder [Inde] ; R. Gutierrez-Bonet [Espagne]The role of tocilizumab in the treatment of inflammatory diseases of the eye and orbit: A useful alternative.
001243 (2018) Golam M. Khandaker [Royaume-Uni] ; Bianca P. Oltean [Royaume-Uni] ; Muzaffer Kaser [Royaume-Uni] ; Claire R M. Dibben [Royaume-Uni] ; Rajini Ramana [Royaume-Uni] ; Deepak R. Jadon [Royaume-Uni] ; Robert Dantzer [États-Unis] ; Alasdair J. Coles [Royaume-Uni] ; Glyn Lewis [Royaume-Uni] ; Peter B. Jones [Royaume-Uni]Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation.
001336 (2018) Ahmed M. Adlan [Royaume-Uni]Inflammation and Heart Rate-corrected QT Interval: Evidence for a Potentially Reversible Cause of Sudden Death in Patients with Rheumatoid Arthritis?
001348 (2018) Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
001389 (2018) Shiang-Fen Huang [République populaire de Chine] ; Ming-Han Chen [République populaire de Chine] ; Fu-Der Wang [République populaire de Chine] ; Chang-Youh Tsai [République populaire de Chine] ; Chang-Phone Fung [République populaire de Chine] ; Wei-Juin Su [République populaire de Chine]Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
001420 (2018) Alison O'Mahony [États-Unis] ; Markus R. John [Suisse] ; Hannah Cho [États-Unis] ; Misato Hashizume [Suisse] ; Ernest H. Choy [Royaume-Uni]Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate.
001443 (2018) Amany El-Shahawy Abdel-Maged [Égypte] ; Amany M. Gad [Égypte] ; Amal Kamal Abdel-Aziz [Égypte] ; Mohammad M. Aboulwafa [Égypte] ; Samar S. Azab [Égypte]Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis.
001484 (2018) E L Nasonov [Russie] ; T V Popkova [Russie]Atherosclerosis: perspectives of anti-inflammatory therapy.
001488 (2018) Yi-Ming Chen [Taïwan] ; Chun-Yu Chang [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Kuo-Tung Tang [Taïwan] ; Meng-Chun Yang [Taïwan] ; Joung-Liang Lan [Taïwan] ; Der-Yuan Chen [Taïwan]Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy.
001546 (2017) François Spertini [Suisse][Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab].
001552 (2017) Margarita Candil [Suisse] ; Pascal Zufferey [Suisse][Anti-IL-6 : new therapeutic trends].
001560 (2017) Cosimo Bruni [Italie] ; Emanuela Praino [Italie] ; Yannick Allanore [France] ; Oliver Distler [Suisse] ; Armando Gabrielli [Italie] ; Florenzo Iannone [Italie] ; Marco Matucci-Cerinic [Italie]Use of biologics and other novel therapies for the treatment of systemic sclerosis.
001606 (2017) Patricia Ruiz-Lim N [Espagne] ; Rafaela Ortega [Espagne] ; Ivan Arias De La Rosa [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Carlos Perez-Sanchez [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Esther Peralbo-Santaella [Espagne] ; Pilar Font [Espagne] ; Desiree Ruiz-Vilches [Espagne] ; Gustavo Ferrin [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Chary L Pez-Pedrera [Espagne] ; Nuria Barbarroja [Espagne]Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Inflammation" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Inflammation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Inflammation
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021